Dr. Murray

A young woman with Dysautonomia recovers with the help of her faith in God and one remarkable physician.

Dr. Murray was the physician for me and my autonomic system. There are many reasons but these four are related to the book, the Great Physician, the Autonomic System, Trixie, and Defeating Dysautonomia.

First, he knew that Jesus was my Great Physician and he encouraged me to read my bible daily. For that, I am grateful and reminded regularly.

Dr. Murray restarted my autonomic system, rebuilding it like a car that had stopped by the side of the road. With each service, he encouraged me and assigned me homework.

Dr. Murray loved Trixie. He watched how she interacted with me and how it could help then we discussed that plan of action.

Dr. Murray was ecstatic about Defeating Dysautonomia. He spent hours teaching me the medical terminology of the autonomic system. Like any great teacher, he assigned a textbook. I worked hard to follow my mentor and study carefully.

From the beginning, Dr. Murray wanted me to know writing a book is hard. I respect him for his honesty. Knowing that I beat dysautonomia made it easier along the way. He also wanted the Immune System discussed.

Publications by Dr. Murray

Murray GL; Rockett JF; Conner MJ; The Different Radionuclide Angiography RNA) Responses to Upright Bicycle Ergometer Exercise in a Population with Low Probability Coronary Disease.  Clinical Nuclear Medicine 9:687, 1984.


Murray GL; Rockett JF: (abstract).  The Superiority of Functional Cardiac Imaging for Diagnostic Coronary Disease.  Clinical Nuclear Medicine 10S:39, 1985.


Stagg SJ; Walker CM; Ladd WR; Murray GL; Fudge TL; Allie DE; Chiasson G: Percutaneous Laser Angioplasty Unblocks Vessel at its Origin Clinical Laser Monthly-Clinical Practice Report, 1988.  Volume 6, No. 5.


Murray GL; Schad N; Ladd WR; et al: Functional Cardiac Imaging in Coronary Disease: Increased Sensitivity of First-pass Radionuclide Angiography Utilizing Sequential Regional Left Ventricular Early Diastolic Filling Rate Image.  Cardiologia, 1990, 35, 25.


Rockett JF; Magill HL; Loveless VS; Murray GL: Intravenous Dipyridamole Thallium-201 SPECT: Methodology, Applications, and Interpretations.  Clinical Nuclear Medicine, 1990, 15:7 12.


Murray GL; Cowan GS; Golden S; et al: Exercise Induced Wall Motion Abnormalities and Resting Left Ventricular Dysfunction in the Morbidly Obese as assessed by Radionuclide Ventriculography.  International Journal of Obesity, 11th (2): 214, 1987.


Murray GL; Schad N; Ladd W: et al: Metabolic Cardiac Imaging in Severe Coronary Disease: Assessment of Viability with Iodine—123-Ilodophenylpenta-Decanoic Acid and Multicrystal Gamma Camera, and Correlation with Biopsy.  Journal of Nuclear Medicine, 1992, 33: 1269


Murray GL; Magill HL; Schad NC: (abstract).  Assessing Myocardial Viability: Comparison of Reinjection SPECT Thallium and Low Dose Dynamic 123- Iodophenylpenta-Decanoic Acid Metabolic Imaging.  Europe Journal Nuclear Medicine 1993, 20 (10): 879, 1993.


Murray GL; Schad NC; Magill HL: Dynamic Low Dose I-123

Iodophenylpentadecanoic Acid Metabolic Cardiac Imaging: Comparison to myocardial biopsy and reinjection SPECT Thallium in Ischemic cardiomyopathy and Cardiac Transplantation.  Annals of Nuclear Medicine Vol. 7, S1J-79-S11-85, 1993.


Murray GL; Shad NC; Magill HL; Vanderwaag RV: Myocardial Viability Assessment with Dynamic Comparison with Myocardial Biopsy and Re-injection SPECT Thallium after Myocardial Infarction.  Journal of Nuclear Medicine, Vol. 35. No 4, (suppl), April 1994.

Presentations by Dr. Murray

Murray GL; Rockett JF: Exercise Induced Wall Motion Abnormalities and Resting Left Ventricular Dysfunction in the Morbidly Obese as Assessed by Radionuclide Ventriculography.  Sixth Annual International Symposium “Surgical Treatment of Obesity 1988”—March 1988.  Memphis, TN.


Murray GL; IPPA Metabolic Imaging.  New Cardiovascular Intervention Symposium—May 1989.  New Orleans, Louisiana.


Murray GL; Metabolic Cardiac Imaging.  San Francisco Heart Institute—June 26, 1989. Seton Medical Center, Daly City, California.


Murray GL; Dynamic low dose 1-123-Iodophenypentadecanoic Acid Metabolic Cardiac Imaging.  Presented at the 3rd International Workshop in Radioiodinated  Free Fatty Acids. February 10-11, 1993. Kyoto, Japan.


Murray GL; Metabolic Cardiac Imaging. St Luke’s Hospital—July 24, 1989. Milwaukee, Wisconsin.


Murray GL; Metabolic Cardiac Imaging. Tulane University—August 3, 1989. New Orleans, Louisiana.


Murray GL; Schad N; Ladd WR; Abgen RP; Stagg SJ; Walker CM; Recognition of Viable Myocardium with 1-123 Iodophenylpenta-Decanoic Acid After Presumed Transmurai Myocardial Infarction.  The Society of Nuclear Medicine 37th Annual Meeting, Washington Convention Center, Washington, D.C. Abstract.


Murray GL; Nuclear Cardiology Update. National AAPA Meeting, May 30, 1990. New Orleans, LA.


Murray GL; Noninvasive Detection of Cardiac Rejection—Low Dose 1-123 Phenylpentadecanoic Acid Parametric Metabolic Imaging. American College Cardiology 41st Annual Scientific Session. April 12-16, 1992.


Murray GL; IPPA Metabolic Imaging. Nuclear Cardiology Seminar on Myocardial Perfusion, Metabolism Function. Oberhausen, Germany. September 19, 1992.

Follow Hope for Team Tara


Pin It on Pinterest